Avenda Health adds Surgery Mode to Unfold AI for prostate cancer care

Avenda Health launched Surgery Mode, an intraoperative feature set for its Unfold AI prostate cancer mapping platform. The system predicts cancer spread with 92% accuracy versus 52% for MRI alone and raises tumor extent sensitivity from 37% to 97%.

• Surgery Mode brings 3D tumor maps into the operating room, including robotic prostatectomies
• Cancer spread prediction accuracy is 92% versus 52% with MRI alone
• Tumor extent sensitivity rose from 37% to 97%
• New tools include camera-aligned Capsule Risk Score, case filters and insurance checks